wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26852544-EEA61790-53E5-4E73-83D2-578929F8C8EB
Q26852544-EEA61790-53E5-4E73-83D2-578929F8C8EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26852544-EEA61790-53E5-4E73-83D2-578929F8C8EB
Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline.
P2860
Q26852544-EEA61790-53E5-4E73-83D2-578929F8C8EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26852544-EEA61790-53E5-4E73-83D2-578929F8C8EB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
24ca9e33071759354900e25b0d0da3349bdbfae2
P2860
Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.